Need Help?

Genomic Rearrangements in Pediatric Cancer

This study contains a collection of samples used to determine the role and impact of genomic rearrangements in a pan cancer pediatric cohort.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001007701 -
EGAD00001008152 -
EGAD00001008272 -
EGAD00001008466 -
EGAD00001008467 -
EGAD00001008709 -
EGAD00001009297 -
EGAD00001009298 -
EGAD00001009793 Illumina NovaSeq 6000 8
EGAD00001009794 Illumina NovaSeq 6000 4
EGAD00001010042 1
EGAD00001010179 1
EGAD00001011378 1
Publications Citations
Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing.
JCO Precis Oncol 6: 2022 e2000504
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.
EMBO Mol Med 14: 2022 e16001
Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors.
Cancers (Basel) 14: 2022 4872
Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma.
Nat Commun 14: 2023 3074
Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.
BMC Cancer 23: 2023 618